|
Adverse event
|
BBP group (%)
|
Non-BBP group (%)
|
|---|
|
Hematological
|
|
Neutropenia
|
6 (16.2)
|
6 (24.0)
|
|
Anemia
|
1 (2.7)
|
4 (16.0)
|
|
Thrombocytopenia
|
1 (2.7)
|
1 (4.0)
|
|
Non-hematological
|
|
Fatigue
|
0 (0)
|
1 (4.0)
|
|
Decreased appetite
|
2 (5.4)
|
2 (8.0)
|
|
Diarrhea
|
2 (5.4)
|
0 (0)
|
|
Hypertension
|
1 (2.7)
|
0 (0)
|
|
Proteinuria
|
1 (2.7)
|
0 (0)
|
|
Gastrointestinal perforation
|
1 (2.7)
|
1 (4.0)
|
|
Bleeding
|
1 (2.7)
|
1 (4.0)
|
|
Venous thromboembolic
|
1 (2.7)
|
0 (0)
|
|
Cerebral infarction
|
1 (2.7)
|
0 (0)
|
|
Ileus
|
1 (2.7)
|
1 (4.0)
|
|
Hepatic infection
|
0 (0)
|
1 (4.0).
|
|
Febrile neutropenia
|
1 (2.7)
|
0 (0)
|
